School of Medicine
Showing 31-40 of 44 Results
-
Marina Francis
Postdoctoral Scholar, Radiation Therapy
BioDr. Francis is a Postdoctoral Scholar in Dr. Everett Moding’s lab at the Department of Radiation Oncology. She uses genomic analysis of patient samples and preclinical models to identify new targets that sensitize sarcoma to treatments like radiation and immunotherapy. Before joining Stanford University, she completed her PhD in Biomedical Sciences at the American University of Beirut, where she worked in Dr. Youssef Zeidan’s lab investigating the role of the sphingolipid-modifying enzyme SMPDL3b in radiation nephropathy. Her research interests revolve around improving cancer treatment outcomes and patients’ quality of life by optimizing radiation therapy, combined treatment strategies, personalized precision oncology, and mitigating collateral treatment-associated toxicities.
-
Julia Gesine Fricke
Postdoctoral Scholar, Radiology
BioDr. Julia G. Fricke is a Swiss board-certified nuclear medicine physician-scientist and Postdoctoral Scholar in the Department of Radiology at Stanford University School of Medicine, supported by a Swiss National Science Foundation (SNSF) Postdoc.Mobility Fellowship.
Her research focuses on theranostics and the clinical translation of novel radiopharmaceuticals, with a particular interest in targeted radionuclide therapy and molecular imaging in oncology. During her clinical and research training at University Hospital Basel, Switzerland, she contributed to the first-in-human clinical evaluation of the somatostatin receptor antagonist [¹⁶¹Tb]Tb-DOTA-LM3 for neuroendocrine tumor therapy, as well as the clinical investigation of GLP-1 receptor PET/CT using [⁶⁸Ga]Ga-DOTA-exendin-4 for insulinoma localization. Her research has been recognized with several distinctions, including the Marie Curie Award at EANM 2024 and the Young Authors Award at EANM 2026.
At Stanford, her research focuses on long-axial-field-of-view PET/CT and its potential to advance the clinical translation of emerging radiopharmaceuticals. Her long-term research interests include the development and clinical translation of innovative molecular imaging and targeted radionuclide therapy strategies.